Phase I Trial of Ribociclib in Combination With Everolimus and Dexamethasone in Children and Young Adults With Relapsed Acute Lymphoblastic Leukemia
Latest Information Update: 13 May 2025
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary) ; Dexamethasone
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 07 May 2025 Planned End Date changed from 1 Apr 2025 to 1 Oct 2025.
- 24 Oct 2024 Planned End Date changed from 30 Sep 2024 to 1 Apr 2025.
- 12 Feb 2024 Planned End Date changed from 1 Mar 2024 to 30 Sep 2024.